Literature DB >> 3945267

Relation between complications of type I diabetes mellitus and collagen-linked fluorescence.

V M Monnier, V Vishwanath, K E Frank, C A Elmets, P Dauchot, R R Kohn.   

Abstract

Nonenzymatically glycosylated proteins gradually form fluorescent cross-linked protein adducts--a process termed "browning." The rate of this reaction increases with the glucose concentration. Assaying for the presence of browning products in long-lived proteins should therefore provide information on long-term metabolic control. We measured collagen-linked fluorescence typical for nonenzymatic browning in skin-biopsy specimens from 41 subjects with longstanding Type I diabetes and from 25 controls. Fluorescence correlated with age and (weakly) with the duration of diabetes. Mean age-adjusted fluorescence values were twice as high in diabetic subjects as in control subjects (P less than 0.0001) and increased with the severity of retinopathy, nephropathy, and arterial and joint stiffness. The correlation was significant for retinopathy (r = 0.42; P less than 0.01), arterial stiffness (r = 0.41; P less than 0.01), joint stiffness (r = 0.34; P less than 0.05), and the sum of all complications (r = 0.47; P less than 0.01). Fluorescence also correlated with systolic (r = 0.42; P less than 0.01) and diastolic (r = 0.36; P less than 0.05) blood pressures. If one can assume that the fluorescence results from a browning product of glucose, our data suggest that there is an overall correlation between the severity of diabetic complications and cumulative glycemia over many years.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945267     DOI: 10.1056/NEJM198602133140702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  105 in total

1.  "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.

Authors:  Caatje Y le Poole; Frans J van Ittersum; Rob M Valentijn; Tom Teerlink; Bengt Lindholm; Piet M Ter Wee; Casper G Schalkwijk
Journal:  Perit Dial Int       Date:  2011-05-31       Impact factor: 1.756

2.  Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation.

Authors:  V M Bhor; S Sivakami
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Risk factors for expression and progression of limited joint mobility in insulin-dependent childhood diabetes.

Authors:  J Vuković; M Dumić; A Radica; B Filipović-Grcić; V Jovanović
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 4.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

6.  Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus.

Authors:  H Oxlund; T T Andreassen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

7.  Tissue-advanced glycation end product concentration in dialysis patients.

Authors:  Natasha J McIntyre; Lindsay J Chesterton; Stephen G John; Helen J Jefferies; James O Burton; Maarten W Taal; Richard J Fluck; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 8.237

8.  Simple non-invasive assessment of advanced glycation endproduct accumulation.

Authors:  R Meerwaldt; R Graaff; P H N Oomen; T P Links; J J Jager; N L Alderson; S R Thorpe; J W Baynes; R O B Gans; A J Smit
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

9.  Genetic risk factors in diabetic retinopathy.

Authors:  L L Stewart; L L Field; S Ross; R G McArthur
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

Authors:  P J Beisswenger; L L Moore; T Brinck-Johnsen; T J Curphey
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.